Stryker sees FY13 adjusted EPS $4.20-$4.26, consensus $4.23 Sees FY adjusted EPS growth 10%-12%. Sees FY13 organic sales growth 4.5%-5.5%, consensus $8.99B. Capital allocation plans include: M&A to drive growth, dividend growth, share repurchases. Sees 15% increase in dividend for 2014. Comments from slides that are being presented at the JP Morgan Healthcare Conference.